Seadling

Seadling specializes in innovative seaweed-based functional ingredients, enhancing well-being across animals, plants, and humans. The company is committed to sustainable practices within the agri-food sector and caters to diverse clients. Founded in 2018 in Sabah, Malaysia, Seadling develops seaweed-derived solutions for various industries. The company has successfully completed one deal, most recently on March 3, 2025, raising USD 1 million in a Seed funding round from investors including AgFunder and Toyo Seikan Group Holdings, Ltd.

The founder has a background in entrepreneurship, although specific details on prior companies are not available. Seadling's primary offerings revolve around innovative seaweed-based functional ingredients designed to enhance the well-being of animals, plants, and humans. The company emphasizes the sustainable use of seaweed, developing high-quality products that cater to various sectors within the agri-food industry. Key applications include nutritional additives for pet food manufacturers, biostimulants for agricultural use, and health-enhancing ingredients for the food and nutrition industry.

Seadling serves a diverse client base that includes businesses engaged in animal feed production, plant biostimulant manufacturing, and nutritional product development, with products positioned in Southeast Asia and potential outreach to broader international markets. Seadling operates a B2B business model focusing on partnerships with manufacturers and direct collaborations with industry stakeholders. Revenue generation occurs through structured transactions that involve product co-development and tailored ingredient solutions designed for specific client needs. The company engages with clients in the pet food, agricultural, and nutritional industries, establishing agreements that may include long-term supply contracts and project-based collaborations.

While specific pricing details for individual products or services are proprietary, transactions are expected to follow standard industry practices, reflecting the value of high-quality seaweed ingredients and ensuring product safety through established quality control measures. Seadling's revenue structure is supported by its flagship offerings, emphasizing the innovative application of seaweed in enhancing overall health and sustainability across various markets. In March 2025, Seadling raised USD 1 million in Seed funding, which will support its growth by expanding manufacturing capabilities, accelerating product innovation, and reinforcing its global footprint within agriculture, animal health, and human nutrition markets. The company plans to design and launch new products focused on these areas.

Seadling is targeting specific international markets for expansion, although exact regions have not been specified. Recent funding will facilitate these developments, helping to ensure the company meets emerging demands in its sectors.